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Clinical trial registration involves placing the protocol for a 
clinical trial on a free, publicly available and electronically 
searchable register. Registration is considered to be 
prospective if the protocol is registered before the trial 
commences (ie, before the first participant is enrolled). 
Prospective registration has several potential advantages. It 
could help avoid trials being duplicated unnecessarily and 
it could allow people with health problems to identify trials 
in which they might participate. Perhaps more importantly, 
however, it tackles two big problems in clinical research: 
selective reporting and publication bias.
Selective reporting involves investigators only reporting 
the most favourable results when they publish a trial, 
instead of reporting the results for all the outcomes that 
were measured. Reporting only favourable outcomes can 
create a misleading appearance of the effect of a therapy 
in the published literature. For example, imagine that a 
completely ineffective intervention is tested across several 
trials and each trial measures multiple outcomes. Most 
outcomes will show no significant effect of the intervention. 
However, occasionally an outcome will show significant 
benefit or harm simply by chance. If the researchers publish 
the positive outcomes but not all of the non-significant 
and negative outcomes, readers could interpret falsely 
that the intervention is beneficial. A similar problem 
could occur when outcomes are analysed at multiple 
time points. Researchers may report that an intervention 
improves walking speed at 6 months, but fail to mention 
that it does not improve walking speed at 1, 2, 3, 9, 12 
and 24 months. Prospective registration of clinical trials 
combats this problem in several ways. Journal editors and 
reviewers can compare the range of outcomes reported in a 
manuscript against those listed in the registered protocol, 
requesting that any discrepancies be resolved by following 
the protocol. Readers can also compare the outcomes in the 
registered protocol against those in the published report, 
taking greater reassurance when they are consistent. 
Publication bias arises when trials with positive results are 
more likely to be published than trials with non-significant 
or negative results. Like selective reporting, this can also 
spuriously inflate the apparent effect of an intervention 
across the published data. For example, a trial in which 
the intervention appeared to be effective may be published, 
while the three other trials in which the intervention 
appeared ineffective or harmful languish in the filing 
cabinets of the investigators. If a trial is registered but never 
published, authors of a systematic review can still find the 
trial on the register and contact the authors to request the 
unpublished data for inclusion in the review. Therefore, 
prospective registration of clinical trials could further 
limit bias affecting the body of evidence that is available in 
published physiotherapy trials.
Prospective clinical trial registration encourages 
transparency (Sim et al 2006) and may also make it 
more difficult for fraudulent authors to fabricate data. For 
example, some journals now ask for individual patient data 
to be provided routinely for checking (Herbert 2008) or 
audit data when fraud is suspected (Smith & Godlee 2005). 
Data collection should have occurred during the dates of 
data collection defined on the registry. Because many 
outcomes are measured and stored electronically with date 
stamps, this would increase the planning and complexity 
involved in fabricating data, especially if the fabricated data 
are to withstand the scrutiny of an audit. Also, researchers 
who obtain unwelcome data from a particular subgroup of 
patients may be tempted to eliminate it by retrospectively 
introducing an additional exclusion criterion. If their 
protocol has been prospectively registered, however, this 
would be publicly evident to anyone who compared the 
registered protocol and the report of the trial. 
How common is clinical trial registration?
The first major register for healthcare trials was established 
in 1998 (De Angelis et al 2004). Although thousands of 
trials were soon registered, the majority of trials remained 
unregistered. In 2004, clinical trial registration was 
endorsed by the International Committee of Medical Journal 
Editors (ICMJE) (De Angelis et al 2004). In addition to 
endorsing clinical trial registration, member journals of 
the ICMJE made prospective registration compulsory for 
all clinical trials that commenced participant recruitment 
after 1 July 2005 (De Angelis et al 2004). Many other 
journals also endorsed clinical trial registration and the 
number of registered trials increased rapidly (Laine et al 
2007). Since then, many organisations have added their 
support for clinical trial registration. For example, in 2008 
the World Medical Association included a new item on 
the Declaration of Helsinki, stating that ‘Every clinical 
trial must be registered in a publicly accessible database 
before recruitment of the first subject’ (World Medical 
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Association 2008, p3.). Some ethics committees have made 
trial registration a condition of ethical approval.
Although some physiotherapy journals have also encouraged 
clinical trial registration (Askie et al 2006, Harms 2011, 
Costa et al 2010), only about 6% of the randomised trials 
investigating the effects of physiotherapy interventions 
published in 2009 had been registered prospectively (Pinto 
2012). In an attempt to rectify this situation, this editorial 
recommending prospective registration has been co-
authored by several members of the International Society 
of Physiotherapy Journal Editors (ISPJE). The remainder of 
the editorial will: define which trials should be registered; 
explain how researchers can register their trials; announce 
tougher policies about clinical trial registration that are 
being adopted by some member journals of the ISPJE; and 
identify who can contribute to ensuring that clinical trial 
registration achieves its potential benefits.
Which trials should be registered?
Any clinical trial should be prospectively registered before 
the first participant is recruited into the study. The World 
Health Organization defines clinical trials as ‘any research 
study that prospectively assigns human participants or 
groups of humans to one or more health-related interventions 
to evaluate the effects on health outcomes’ (WHO 2012).
How can I register my trial?
Clinical trial registration should be quick, easy, and free of 
charge. Many clinical trial registries have been established, 
including some that focus on a particular disease (eg, 
Internet Stroke Center Trials Registry, www.strokecenter.
org/trials) or geographical region (eg, Pan African Clinical 
Trials Registry, www.pactr.org). Researchers often choose 
to register their trials in their country’s national register, 
although this is not compulsory. It is more important that 
researchers choose a registry that elicits and documents all 
the relevant content from the original protocol (outlined 
below) and that has satisfactory quality, validity, accessibility, 
unique identification, technical capacity and administration. 
To assist researchers, the World Health Organization 
maintains a list of registries that meet these criteria 
(http://www.who.int/ictrp/network/primary/en/index.html). 
Currently 16 registries are listed. Among these, researchers 
could choose one that processes applications swiftly or that 
allows communication using their native language.
When registering their protocol, researchers will be 
asked to provide information such as descriptions of the 
intervention(s) and comparison(s) studied, study hypotheses, 
primary and secondary outcomes, eligibility criteria, sample 
size, blinding, funding, principal investigators, and dates of 
commencement and anticipated completion of the study. It 
is common for trial registries to review the information for 
completeness and clarity, so some editing might be needed. 
The registry will then provide a unique trial registration 
number to the researchers. This number should be included 
in all reports of the trial’s results as a link to the registered 
protocol for editors, reviewers and readers.
Prospective registration can be done any time before the 
first participant is recruited. Many researchers wait until 
immediately before recruitment starts, so that any late 
changes to the protocol (such as alterations requested by an 
ethics committee) do not necessitate an amendment to the 
registry entry. Although not ideal, protocol amendments are 
sometimes made after recruitment starts. These should be 
updated on the registered protocol as well. The trial registry 
will publicly document what changed and on what date.
ISPJE member journals introducing mandatory 
prospective registration policies
The executive of the ISPJE strongly recommends that 
member journals adopt a policy of mandatory prospective 
registration for all clinical trials. Several member journals 
are implementing such policies. Physical Therapy has 
already implemented a policy of mandatory prospective 
clinical trial registration, which applies to trials that 
commenced participant recruitment after 1 January 2009. 
The following table lists other member journals and their 
nominated dates to implement mandatory prospective 
clinical trial registration, as well as the trials that this policy 
applies to (based on the commencement date of participant 
recruitment).
Table 1. Initiation of the policy of mandatory clinical trial registration by participating journals.
Journal Date after which prospective 
clinical trial registration 
becomes mandatory
This policy applies to trials 
that commence participant 
recruitment after this date
Brazilian Journal of Physical Therapy/Revista Brasileira de Fisioterapia 1 January 2014 31 December 2013
Cardiopulmonary Physical Therapy Journal 1 January 2015 1 January 2014
Journal of Manual and Manipulative Therapy 1 January 2014 6 June 2013
Journal of Physiotherapy 1 January 2013 1 January 2006
Journal of Physiotherapy & Sports Medicine 1 January 2014 1 June 2013
Manual Therapy 1 January 2014 1 June 2013
Physical Therapy & Research/Fisioterapia e Pesquisa 1 January 2014 31 December 2013
Physiotherapy 1 January 2013 1 January 2013
Physiotherapy Canada 1 January 2013 1 January 2013
The Journal of Orthopaedic & Sports Physical Therapy 1 January 2013 1 January 2013
Tidsskriftet Fysioterapeuten/Norwegian Journal of Physiotherapy 1 January 2014 1 July 2013
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Who else can help ensure clinical trial 
registration achieves its potential benefits?
In addition to the recommendations for researchers and 
editorial boards outlined above, others can contribute to 
ensuring that clinical trial registration achieves its potential 
benefits. Everyone in the profession can ensure that their 
colleagues are aware of clinical trial registration and its 
importance. Educators should ensure that the research 
component of physiotherapy training programs explains the 
importance of trial registration. Clinicians can also advise 
or help patients to search trial registers to identify relevant 
trials for which the patient might volunteer. Administrators 
of clinical trial registries that do not meet the WHO criteria 
can strive to attain this status. Grant review panels can 
make funding contingent upon prospective registration for 
proposed clinical trials. More ethics review committees can 
make their approval of trials contingent upon prospective 
registration as well. However, even universal prospective 
registration may make no difference to selective reporting 
and publication bias unless there is an expectation that 
protocols will be compared to published reports before 
publication. Therefore, journal editors and peer reviewers 
must remember to check for discrepancies between 
submitted manuscripts and registry entries.
Physiotherapy clinical trials that are conducted and 
reported according to a pre-specified protocol are more 
likely to provide credible information than those that do not. 
Prospective clinical trial registration is therefore of great 
potential value to the clinicians, consumers and researchers 
who rely upon clinical trial data, and that is why ISPJE is 
recommending that members enact a policy for prospective 
trial registration.
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